When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant improvements in progression-free and overall survival were seen.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/pembro-plus-weekly-paclitaxel-boosts-ovarian-cancer-survival-2025a1000sjk?src=rss
Author :
Publish date : 2025-10-21 13:54:00
Copyright for syndicated content belongs to the linked Source.